Development of Cyclometalated Iridium(III) Complexes of 2‐Phenylbenzimidazole and Bipyridine Ligands for Selective Elimination of Gram‐Positive Bacteria
Chemistry – An Asian Journal · 17.01.2025 · 20 (2)
DOI: 10.1002/asia.202401060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 23.11.2024. Verfasst von Aryan Gautam und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. Hauptthemen laut MEDLINE: Iridium, Anti-Bacterial Agents, Benzimidazoles, Gram-Positive Bacteria. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: MHRD-STARS, BRNS, SERB, DST.
Abstract (Originalsprache)
Herein, we have reported a series of cationic aggregation‐induced emission (AIE) active iridium(III) complexes ( Ir1‐Ir5 ) of the type [Ir(C N) 2 (N N)]Cl, wherein C N is a cyclometalating 2‐phenylbenzimidazole ligand with varying alkyl chain lengths and N N is a 2,2’‐bipyridine ligand attached to bis‐polyethylene glycol chains, for the treatment of bacterial infections. The AIE phenomenon of the complexes leveraged for detecting bacteria by fluorescence microscopy imaging that displayed a strong red emission in Gram‐positive bacteria. The antibacterial activity of the complexes assessed against Gram‐positive methicillin‐sensitive S. aureus , methicillin‐resistant S. aureus , E. faecium and E. faecalis and Gram‐negative E. coli and P. aeruginosa bacteria of clinical interest. The complexes Ir2‐Ir4 exerted potent antibacterial activity towards Gram‐positive strains with low minimum inhibitory concentrations (MICs) values in the range of 1–9 μM, which is comparable to clinically approved antibiotic vancomycin. In contrast, these complexes were found to be inactive towards Gram‐negative bacterial strains (MICs >100 μM). The mechanism of antibacterial activity of the complexes implies that ROS generation, membrane depolarization and rupture are responsible for bacterial cell death. Further, the complexes Ir1‐Ir3 were found to be low‐toxic against human red blood cells and human embryonic kidney (HEK293) cells, indicating their potential for use as antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
- Amity Institute of Click Chemistry Research and Studies, Amity University, Noida, Uttar Pradesh, 201303, India.
ORCID-Profile: Pijus K Sasmal
Förderung
- MHRD-STARS
- BRNS
- SERB, DST
- Board of Research in Nuclear Sciences
Zitieren
APA
Gautam, A., Gupta, A., Prasad, P., & Sasmal, P. K. (2025). Development of Cyclometalated Iridium(III) Complexes of 2‐Phenylbenzimidazole and Bipyridine Ligands for Selective Elimination of Gram‐Positive Bacteria. Chemistry – An Asian Journal, 20(2). https://doi.org/10.1002/asia.202401060
Vancouver
Gautam A, Gupta A, Prasad P, Sasmal PK. Development of Cyclometalated Iridium(III) Complexes of 2‐Phenylbenzimidazole and Bipyridine Ligands for Selective Elimination of Gram‐Positive Bacteria. Chemistry – An Asian Journal. 2025;20(2). doi:10.1002/asia.202401060
BibTeX
@article{Gautam2025,
author = {Gautam, Aryan and Gupta, Ajay and Prasad, Puja and Sasmal, Pijus K},
title = {Development of Cyclometalated Iridium(III) Complexes of 2‐Phenylbenzimidazole and Bipyridine Ligands for Selective Elimination of Gram‐Positive Bacteria},
journal = {Chemistry – An Asian Journal},
year = {2025},
volume = {20},
number = {2},
doi = {10.1002/asia.202401060}
}
EUVIMED